Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST
Tenaya Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 190 | 221 | 129 | 782 | - | - |
| Market Cap Growth | -37.99% | 71.58% | -83.56% | - | - | - |
| Enterprise Value | 106 | 105 | -5 | 518 | - | - |
| Last Close Price | 2.41 | 3.24 | 2.01 | 18.95 | - | - |
| PE Ratio | - | -1.93 | -0.73 | -4.62 | - | - |
| PB Ratio | 1.42 | 1.58 | 0.53 | 2.81 | - | - |
| P/FCF Ratio | -2.46 | -2.14 | -1.03 | -9.10 | - | - |
| P/OCF Ratio | -2.49 | -2.16 | -1.23 | -12.86 | - | - |
| EV/EBITDA Ratio | -1.12 | -0.85 | 0.04 | -7.42 | - | - |
| EV/EBIT Ratio | -1.04 | -0.80 | 0.04 | -7.12 | - | - |
| EV/FCF Ratio | -1.34 | -1.01 | 0.04 | -6.03 | - | - |
| Debt / Equity Ratio | 0.12 | 0.09 | 0.06 | 0.06 | - | - |
| Debt / FCF Ratio | -0.16 | -0.12 | -0.12 | -0.18 | - | - |
| Quick Ratio | 5.94 | 4.60 | 7.79 | 11.54 | 25.50 | 6.46 |
| Current Ratio | 6.28 | 4.91 | 7.99 | 11.73 | 25.78 | 6.73 |
| Return on Equity (ROE) | -74.54% | -64.83% | -47.39% | -34.80% | -45.51% | - |
| Return on Assets (ROA) | -41.33% | -36.49% | -26.47% | -19.68% | -26.13% | - |
| Return on Capital (ROIC) | -45.00% | -39.97% | -28.41% | -20.99% | -28.82% | - |
| Earnings Yield | -63.50% | -56.23% | -96.15% | -9.30% | - | - |
| FCF Yield | -52.01% | -46.81% | -97.23% | -10.98% | - | - |
| Buyback Yield / Dilution | -29.65% | -64.61% | -152.75% | -1724.33% | -28.62% | - |
| Total Shareholder Return | -29.65% | -64.61% | -152.75% | -1724.33% | -28.62% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.